| ADMA | Asymmetric dimethylarginine |
| AGE | Advanced glycation end-product |
| BAV | Bicuspid aortic valve |
| CHD | Congenital heart disease |
| CT | Computed tomography |
| ECM | Extracellular matrix |
| esRAGE | Endogenous secretory RAGE |
| MMP | Matrix metalloproteinase |
| MRI | Magnetic resonance imaging |
| MT-MMP | Membrane-type matrix metalloproteinase |
| NF-κB | Nuclear-factor kappa-B |
| NO | Mitric oxide |
| Nos3 | Nitric oxide synthase-3 enzyme |
| SMC | Smooth muscle cell |
| SNP | Single nucleotide polymorphisms |
| sRAGE | Soluble receptor for advanced glycation end-products |
| TAV | Tricuspid aortic valve |
| TAWSS | Time average wall shear stress |
| TGF-β | Transforming growth factor beta |
| TIMP | Tissue inhibitor of metalloproteinase |
| TLR | Toll-like receptor |
| TOE | Transoesophageal echocardiography |
| TOF | Tetralogy of Fallot |
| TTE | Transthoracic echocardiography |
| VSD | Ventricular septal defect |
| WSS | Wall shear stress |